Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f77c2c1c6a5-trace').style.display = (document.getElementById('cakeErr67f77c2c1c6a5-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f77c2c1c6a5-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f77c2c1c6a5-code').style.display = (document.getElementById('cakeErr67f77c2c1c6a5-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f77c2c1c6a5-context').style.display = (document.getElementById('cakeErr67f77c2c1c6a5-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f77c2c1c6a5-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f77c2c1c6a5-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 24432,
		&#039;title&#039; =&gt; &#039;A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 26 March, 2014, http://www.thehindu.com/sci-tech/health/a-new-challenge-introducing-injectable-polio-vaccine/article5835842.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 24611,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 24432,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Vaccination,Polio,Health,Child Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu



For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 24432,
	&#039;title&#039; =&gt; &#039;A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 26 March, 2014, http://www.thehindu.com/sci-tech/health/a-new-challenge-introducing-injectable-polio-vaccine/article5835842.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 24611,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 24432
$metaTitle = &#039;LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;
$metaKeywords = &#039;Vaccination,Polio,Health,Child Health&#039;
$metaDesc = &#039;
-The Hindu



For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj | Im4change.org</title>
    <meta name="description" content="
-The Hindu



For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>A new challenge: introducing injectable polio vaccine-N Gopal Raj</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu</div><p align="justify"><br /><em>For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.</em></p><p align="justify">India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.</p><p align="justify">The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.</p><p align="justify">Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &lsquo;circulating vaccine-derived polioviruses' (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.</p><p align="justify">More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.</p><p align="justify">The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.</p><p align="justify">But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.</p><p align="justify">Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.</p><p align="justify">If IPV had been introduced in India's routine immunisation programme and OPV used in mass campaigns, &quot;we could have eliminated polio decades ago,&quot; writes Dr. Jacob John in an article appearing in the Economic &amp; Political Weekly next month.</p><p align="justify">A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.</p><p align="justify">But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.</p><p align="justify">Lessons from India's success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f77c2c1c6a5-trace').style.display = (document.getElementById('cakeErr67f77c2c1c6a5-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f77c2c1c6a5-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f77c2c1c6a5-code').style.display = (document.getElementById('cakeErr67f77c2c1c6a5-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f77c2c1c6a5-context').style.display = (document.getElementById('cakeErr67f77c2c1c6a5-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f77c2c1c6a5-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f77c2c1c6a5-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 24432,
		&#039;title&#039; =&gt; &#039;A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 26 March, 2014, http://www.thehindu.com/sci-tech/health/a-new-challenge-introducing-injectable-polio-vaccine/article5835842.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 24611,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 24432,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Vaccination,Polio,Health,Child Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu



For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 24432,
	&#039;title&#039; =&gt; &#039;A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 26 March, 2014, http://www.thehindu.com/sci-tech/health/a-new-challenge-introducing-injectable-polio-vaccine/article5835842.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 24611,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 24432
$metaTitle = &#039;LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;
$metaKeywords = &#039;Vaccination,Polio,Health,Child Health&#039;
$metaDesc = &#039;
-The Hindu



For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj | Im4change.org</title>
    <meta name="description" content="
-The Hindu



For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>A new challenge: introducing injectable polio vaccine-N Gopal Raj</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu</div><p align="justify"><br /><em>For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.</em></p><p align="justify">India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.</p><p align="justify">The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.</p><p align="justify">Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &lsquo;circulating vaccine-derived polioviruses' (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.</p><p align="justify">More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.</p><p align="justify">The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.</p><p align="justify">But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.</p><p align="justify">Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.</p><p align="justify">If IPV had been introduced in India's routine immunisation programme and OPV used in mass campaigns, &quot;we could have eliminated polio decades ago,&quot; writes Dr. Jacob John in an article appearing in the Economic &amp; Political Weekly next month.</p><p align="justify">A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.</p><p align="justify">But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.</p><p align="justify">Lessons from India's success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f77c2c1c6a5-trace').style.display = (document.getElementById('cakeErr67f77c2c1c6a5-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f77c2c1c6a5-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f77c2c1c6a5-code').style.display = (document.getElementById('cakeErr67f77c2c1c6a5-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f77c2c1c6a5-context').style.display = (document.getElementById('cakeErr67f77c2c1c6a5-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f77c2c1c6a5-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f77c2c1c6a5-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 24432,
		&#039;title&#039; =&gt; &#039;A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 26 March, 2014, http://www.thehindu.com/sci-tech/health/a-new-challenge-introducing-injectable-polio-vaccine/article5835842.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 24611,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 24432,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Vaccination,Polio,Health,Child Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu



For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 24432,
	&#039;title&#039; =&gt; &#039;A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 26 March, 2014, http://www.thehindu.com/sci-tech/health/a-new-challenge-introducing-injectable-polio-vaccine/article5835842.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 24611,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 24432
$metaTitle = &#039;LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj&#039;
$metaKeywords = &#039;Vaccination,Polio,Health,Child Health&#039;
$metaDesc = &#039;
-The Hindu



For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;For India, which has successfully kept naturally-occurring &amp;lsquo;wild&#039; polioviruses at bay for three whole years, a new challenge looms.&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &amp;lsquo;circulating vaccine-derived polioviruses&#039; (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;If IPV had been introduced in India&#039;s routine immunisation programme and OPV used in mass campaigns, &amp;quot;we could have eliminated polio decades ago,&amp;quot; writes Dr. Jacob John in an article appearing in the Economic &amp;amp; Political Weekly next month.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Lessons from India&#039;s success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj | Im4change.org</title>
    <meta name="description" content="
-The Hindu



For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>A new challenge: introducing injectable polio vaccine-N Gopal Raj</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu</div><p align="justify"><br /><em>For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.</em></p><p align="justify">India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.</p><p align="justify">The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.</p><p align="justify">Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &lsquo;circulating vaccine-derived polioviruses' (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.</p><p align="justify">More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.</p><p align="justify">The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.</p><p align="justify">But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.</p><p align="justify">Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.</p><p align="justify">If IPV had been introduced in India's routine immunisation programme and OPV used in mass campaigns, &quot;we could have eliminated polio decades ago,&quot; writes Dr. Jacob John in an article appearing in the Economic &amp; Political Weekly next month.</p><p align="justify">A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.</p><p align="justify">But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.</p><p align="justify">Lessons from India's success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 24432,
		'title' => 'A new challenge: introducing injectable polio vaccine-N Gopal Raj',
		'subheading' => '',
		'description' => '<div align="justify">
-The Hindu
</div>
<p align="justify">
<br />
<em>For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.</em>
</p>
<p align="justify">
India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.
</p>
<p align="justify">
The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.
</p>
<p align="justify">
Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &lsquo;circulating vaccine-derived polioviruses' (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.
</p>
<p align="justify">
More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.
</p>
<p align="justify">
The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.
</p>
<p align="justify">
But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.
</p>
<p align="justify">
Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.
</p>
<p align="justify">
If IPV had been introduced in India's routine immunisation programme and OPV used in mass campaigns, &quot;we could have eliminated polio decades ago,&quot; writes Dr. Jacob John in an article appearing in the Economic &amp; Political Weekly next month.
</p>
<p align="justify">
A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.
</p>
<p align="justify">
But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.
</p>
<p align="justify">
Lessons from India's success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.
</p>',
		'credit_writer' => 'The Hindu, 26 March, 2014, http://www.thehindu.com/sci-tech/health/a-new-challenge-introducing-injectable-polio-vaccine/article5835842.ece?homepage=true',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 24611,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 24432,
	'metaTitle' => 'LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj',
	'metaKeywords' => 'Vaccination,Polio,Health,Child Health',
	'metaDesc' => '
-The Hindu



For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce...',
	'disp' => '<div align="justify">-The Hindu</div><p align="justify"><br /><em>For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.</em></p><p align="justify">India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.</p><p align="justify">The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.</p><p align="justify">Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &lsquo;circulating vaccine-derived polioviruses' (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.</p><p align="justify">More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.</p><p align="justify">The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.</p><p align="justify">But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.</p><p align="justify">Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.</p><p align="justify">If IPV had been introduced in India's routine immunisation programme and OPV used in mass campaigns, &quot;we could have eliminated polio decades ago,&quot; writes Dr. Jacob John in an article appearing in the Economic &amp; Political Weekly next month.</p><p align="justify">A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.</p><p align="justify">But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.</p><p align="justify">Lessons from India's success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 24432,
	'title' => 'A new challenge: introducing injectable polio vaccine-N Gopal Raj',
	'subheading' => '',
	'description' => '<div align="justify">
-The Hindu
</div>
<p align="justify">
<br />
<em>For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.</em>
</p>
<p align="justify">
India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.
</p>
<p align="justify">
The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.
</p>
<p align="justify">
Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &lsquo;circulating vaccine-derived polioviruses' (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.
</p>
<p align="justify">
More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.
</p>
<p align="justify">
The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.
</p>
<p align="justify">
But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.
</p>
<p align="justify">
Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.
</p>
<p align="justify">
If IPV had been introduced in India's routine immunisation programme and OPV used in mass campaigns, &quot;we could have eliminated polio decades ago,&quot; writes Dr. Jacob John in an article appearing in the Economic &amp; Political Weekly next month.
</p>
<p align="justify">
A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.
</p>
<p align="justify">
But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.
</p>
<p align="justify">
Lessons from India's success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.
</p>',
	'credit_writer' => 'The Hindu, 26 March, 2014, http://www.thehindu.com/sci-tech/health/a-new-challenge-introducing-injectable-polio-vaccine/article5835842.ece?homepage=true',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'a-new-challenge-introducing-injectable-polio-vaccine-n-gopal-raj-24611',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 24611,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 24432
$metaTitle = 'LATEST NEWS UPDATES | A new challenge: introducing injectable polio vaccine-N Gopal Raj'
$metaKeywords = 'Vaccination,Polio,Health,Child Health'
$metaDesc = '
-The Hindu



For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.


India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce...'
$disp = '<div align="justify">-The Hindu</div><p align="justify"><br /><em>For India, which has successfully kept naturally-occurring &lsquo;wild' polioviruses at bay for three whole years, a new challenge looms.</em></p><p align="justify">India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year.</p><p align="justify">The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence.</p><p align="justify">Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such &lsquo;circulating vaccine-derived polioviruses' (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia.</p><p align="justify">More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back.</p><p align="justify">The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains.</p><p align="justify">But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment.</p><p align="justify">Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion.</p><p align="justify">If IPV had been introduced in India's routine immunisation programme and OPV used in mass campaigns, &quot;we could have eliminated polio decades ago,&quot; writes Dr. Jacob John in an article appearing in the Economic &amp; Political Weekly next month.</p><p align="justify">A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation.</p><p align="justify">But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered.</p><p align="justify">Lessons from India's success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

A new challenge: introducing injectable polio vaccine-N Gopal Raj

-The Hindu For India, which has successfully kept naturally-occurring ‘wild' polioviruses at bay for three whole years, a new challenge looms. India is among 140 countries that rely on the oral polio vaccine (OPV). These countries have now been asked to introduce an injectable inactivated polio vaccine (IPV) into their routine childhood immunisation programme by the end of next year. The oral vaccine, which is cheap and easily administered, uses live but weakened forms of the poliovirus. But the live vaccine viruses can occasionally revert to virulence. Vaccine-derived viruses can gain the ability to transmit within communities and even pass from one country to another. Such ‘circulating vaccine-derived polioviruses' (cVDPV) have struck over 700 children since the year 2000, producing outbreaks in several countries, including Pakistan, Afghanistan, Nigeria and Somalia. More than 95 per cent of the cVPDV cases in recent years have been of the type 2 strain (the poliovirus has three strains, types 1, 2 and 3). Polio caused by a wild type 2 virus was, on the other hand, last seen 15 years back. The Global Polio Eradication Initiative (GPEI), which coordinates the global fight again polio, therefore wants to stop all use of OPV that contains the type 2 vaccine strain. Trivalent OPV, with all three types of vaccine strains, is to be replaced by bivalent OPV with only type 1 and type 3 vaccine strains. But before making that switch, the GPEI has asked all countries using trivalent OPV to introduce at least one dose of the injectable IPV vaccine into their routine immunisation programme. IPV, which is more expensive, uses killed forms of the three types of wild viruses and carries no risk of reversion to virulence. This vaccine would provide protection against any type 2 vaccine-derived viruses lingering in the environment. Trials carried out with IPV in Tamil Nadu around the 1980s by veteran virologist T. Jacob John and his colleagues at the Christian Medical College at Vellore had found that the injectable vaccine was very effective against the poliovirus in an Indian context. An independent effort that tested IPV in Mumbai slums came to the same conclusion. If IPV had been introduced in India's routine immunisation programme and OPV used in mass campaigns, "we could have eliminated polio decades ago," writes Dr. Jacob John in an article appearing in the Economic & Political Weekly next month. A multi-centre study under way in the country is examining the immunity that would be provided when bivalent OPV and IPV are employed in routine childhood immunisation. But for IPV to be effectively deployed, routine immunisation coverage has to be improved. According to the National Family Health Survey of 2005-06, while over 80 per cent of children in Tamil Nadu had received all basic vaccinations, only 23 per cent of those in Uttar Pradesh and 33 per cent in Bihar were similarly covered. Lessons from India's success in polio eradication are being used to enhance routine immunisation and reach under-served communities. This includes drawing up comprehensive micro-plans for routine immunisation, intensively training frontline health workers who will carry out vaccinations and putting in place monitoring systems so that corrective measures can be taken when needed.